168 related articles for article (PubMed ID: 5401649)
1. [Psychopharmacotherapy in internal diseases].
Kielholz P
Verh Dtsch Ges Inn Med; 1969; 75():831-7. PubMed ID: 5401649
[No Abstract] [Full Text] [Related]
2. [Experience with the new tranquilizing agent Wy 4036 (lorazepam) in the specialties psychiatric neurology and internal medicine].
Leube H; Höffkes H
Arzneimittelforschung; 1971 Jul; 21(7):1098-102. PubMed ID: 5109550
[No Abstract] [Full Text] [Related]
3. Psychopharmacology for psychiatric and psychiatric-organic diseases.
Abrams RS
Compr Ther; 1978 May; 4(5):26-32. PubMed ID: 657771
[No Abstract] [Full Text] [Related]
4. [Utilization of psychopharmacological agents in internal medicine].
Relke W
Dtsch Gesundheitsw; 1972 Oct; 27(43):2043-6. PubMed ID: 4564076
[No Abstract] [Full Text] [Related]
5. [Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group].
Appel P; Berger I; Harrer G
Arzneimittelforschung; 1971 Jul; 21(7):1083-6. PubMed ID: 4935400
[No Abstract] [Full Text] [Related]
6. [Clinical studies with oxypertine in chronically psychotic patients].
Eckmann F; Badalik L
Arzneimittelforschung; 1970 Feb; 20(2):268-9. PubMed ID: 5467473
[No Abstract] [Full Text] [Related]
7. Management strategies for problem behaviors in the patient with dementia.
Lehninger FW; Ravindran VL; Stewart JT
Geriatrics; 1998 Apr; 53(4):55-6, 66-8, 71-5. PubMed ID: 9559028
[TBL] [Abstract][Full Text] [Related]
8. [Progress and limitation of psychopharmacological therapy].
Hoff H; Hofmann G
Psychiatr Neurol Med Psychol (Leipz); 1967 Dec; 19(12):441-8. PubMed ID: 6082949
[No Abstract] [Full Text] [Related]
9. [Use of sordinol in mental disordes of vascular origin].
Romanova IS; Banshchikov VM; Rozhanets RV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1223-8. PubMed ID: 5700590
[No Abstract] [Full Text] [Related]
10. [Psychotropic agents in myocardial infarction].
Rybakowski J
Pol Tyg Lek; 1971 Mar; 26(9):319-21. PubMed ID: 4927763
[No Abstract] [Full Text] [Related]
11. [Clinical observations on the use of anti-emotive drug].
Alberto S; Colongo PG; Brusasco L
Arch Sci Med (Torino); 1966 Oct; 122(4):285-301. PubMed ID: 5973479
[No Abstract] [Full Text] [Related]
12. [The application of psychopharmacologic drugs in internal medicine].
Schmid E
Internist (Berl); 1967 Sep; 8(9):322-8. PubMed ID: 4872940
[No Abstract] [Full Text] [Related]
13. [Possibilities in the therapy of psychoneuroses using medazepam (Nobrium)].
Vencovský E; Loughrey-Grofová E
Psychiatr Neurol Med Psychol (Leipz); 1973 Nov; 25(11):695-7. PubMed ID: 4778476
[No Abstract] [Full Text] [Related]
14. [Treatment with Gerioptil and Gerioptil plus H3].
Albach E
Z Allgemeinmed; 1971 Nov; 47(32):1713-6. PubMed ID: 5137905
[No Abstract] [Full Text] [Related]
15. [New findings in the psychopharmacology of sleep].
Vojtĕchovsky M
Act Nerv Super (Praha); 1970 Jan; 12(1):12-21. PubMed ID: 4908187
[No Abstract] [Full Text] [Related]
16. [Therapy of psycho-autonomic and dysphoric syndromes in the general practice].
Maiss HJ
Med Klin; 1968 May; 63(18):727-30. PubMed ID: 5719912
[No Abstract] [Full Text] [Related]
17. [Experiences with a new anxiolytic agent in the general practice].
Vorberg G
Z Allgemeinmed; 1972 Jul; 48(19):909-10. PubMed ID: 4640139
[No Abstract] [Full Text] [Related]
18. [Therapy of the primary symptom anxiety in neuroses, abnormal experience reactions, neuro-vegative psychosomatic disorders and depressions].
Guthy H; Hildgen J; Brinkmann G
Arzneimittelforschung; 1971 Jul; 21(7):1095-7. PubMed ID: 5109351
[No Abstract] [Full Text] [Related]
19. [Clinical tests of the anxiolytic effect of clopenthixol in small doses].
Bovi A
G Psichiatr Neuropatol; 1970; 98(3-4):521-8. PubMed ID: 5512709
[No Abstract] [Full Text] [Related]
20. [A new treatment in current psychiatric practice: Sedalium].
Dubois JC; Dacharry JC; Demoures JM
Ann Med Psychol (Paris); 1970 Feb; 1(2):276-93. PubMed ID: 5420925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
